AbbVie Pty Ltd

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs more than 29,000 people worldwide and markets medicines in over 170 countries.1 Our heritage in Australia reaches back more than 75 years and we employ more than 280 people with a focus on Immunology, Liver Disease, Neuroscience and Oncology. Our therapies currently benefit more than 31,000 Australians.1

For further information please visit  Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

This year marks the 10th anniversary of PBS listing for HUMIRA (adalimumab) for Crohn’s Disease.2

1. AbbVie Data on File VV-05616 2. AbbVie Data on File. AU-IMM-0387.
2. AU-HUMG-0758. Date of preparation: July 2018.

Stand/Booth No. 41